Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Clinical Diagnosis

  • You have access
    Analysis of 18F-FDG PET-CT SUVmax, ER, PR, HER-2, Ki-67, p53 in predicting efficacy of neoadjuvant chemotherapy in breast cancer
    Yan-lin Feng and WEN LI
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1314;
  • You have access
    The Usefulness of Tc-99m MAA Hepatic Perfusion Imaging to Evaluate Intrahepatic and Extrahepatic Perfusion for Patients with Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.
    Dung-Ling Yu and Jun-Hong Juo
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1333;
  • You have access
    Usefulness of FDG PET/CT dual point images to detect liver lesions
    Barbara Zangheri, Martina Sollini, Luigi Calabrese, Donatella Alberti and Massimo Gasparini
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1332;
  • You have access
    11-C acetate in Hepatocellular Carcinoma Management
    Mark Tann, Mark Green, Justin Sims and James Fletcher
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1329;
  • You have access
    The relation between glucose transporters and various factors in initial and interim 18F-FDG PET/CT images in Diffuse Large B-Cell Lymphoma
    AHYOUNG LEE, Soo Jin Jung, Sang Kyun Bae, Seokmo Lee and Su Jung Choi
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1356;
  • You have access
    FDG-PET/CT for predicting pathologic response of locally advanced breast cancer to neoadjuvant therapy: influence of receptor subtype
    Jason Williams, Lori Arlinghaus, Xia Li, Praveen Pendyala, Richard Abramson, Vandana Abramson, A Bapsi Chakravarthy and Thomas Yankeelov
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1316;
  • You have access
    Is systematic colonoscopy of incidental colonic uptakes detected by 18F-FDG PET/CT safe and always indicated?
    Pierre Gordien, Florian Poullenot, Clement Subtil, David Laharie, Laurence Bordenave and Jean-Baptiste Pinaquy
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1343;
  • You have access
    Multimodality assessment of hepatic focal lesions; PET/CT-MRI fusion
    Lamia Zidan, Mohamed Houseni, Ahmed Kandeel and Shahenda Salem
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1331;
  • You have access
    Correlations between metabolic activity measured by 18F-FDG PET/CT and immunophenotype, lactate dehydrogenase, beta-2 microglobulin of patients with newly diagnosed T-cell lymphoma
    Jianhua Zhang, Yan Fan, Zhanli Fu, Xuchu Zhang, Meng Liu, Lijuan Di and Rong Fu Wang
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1352;
  • You have access
    18F-fluorodeoxglucose (FDG) positron emission tomography (PET) to measure response and prediction of outcome to relapsed/refractory mantle cell lymphoma (MCL) therapy with bendamustine-rituximab (BR)
    D. Lamonica, D. Graf, K. Attwood, M. Munteanu and M. Czuczman
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1351;

Pages

  • Previous
  • Next
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 118
SNMMI

© 2025 SNMMI

Powered by HighWire